Key Takeaways
- • Bluegem Capital Partners' third-generation fund (Bluegem III) has acquired a majority stake in Suavinex, a premium Spanish baby care brand headquartered in Spain with manufacturing operations in Slovakia and Spain.
- • The acquisition positions Suavinex alongside Bluegem's existing portfolio company Béaba to create a leading European baby care company with global reach, specializing in feeding products for newborns to 24-month-old babies.
- • Suavinex, established in 1980, holds significant intellectual property including patented technologies for innovative products like its three-position teat system (launched 1988) and Zero-Zero anti-colic bottle range (2018).
- • The business operates a vertically integrated model with direct sales teams in Spain, Italy, France, and China, plus a growing digital presence and established distributor network globally, generating majority sales from the Spanish market.
- • Bluegem III closed its final fund in February 2026 and has already deployed capital across five investments in diversified consumer subsectors, with typical investment range of €20 million to €75 million.
Summary
Bluegem Capital Partners announced the acquisition of a majority stake in Suavinex, a premium Spanish baby care manufacturer, through its third-generation fund (Bluegem III) via portfolio company Béaba. The transaction combines two established players in the European baby care market to create a market-leading position focused on infant feeding and care products for babies aged newborn to 24 months. While specific transaction valuation was not disclosed, the deal aligns with Bluegem's typical investment ticket size of €20 million to €75 million in western European consumer businesses.
Suavinex brings substantial operational assets and intellectual property to the combined entity. The company, founded in 1980, operates a fully vertically integrated business model with in-house manufacturing facilities in Spain and Slovakia, proprietary engineering capabilities, and a portfolio of worldwide patented products. The company is recognized for innovation in baby care, having pioneered the three-position teat system in 1988—a foundational product that allows flow adaptation based on infant sucking patterns—and more recently launching the Zero-Zero product line featuring anti-colic technology underpinned by medical research.
The acquisition leverages existing market presence and distribution infrastructure. Suavinex generates the majority of revenues through direct sales in Spain via a dedicated sales agent network, while also maintaining dedicated sales teams in Italy, France, and China alongside broader global distribution through partner channels. The company has developed a loyal customer base with strong repeat purchase and recommendation patterns, complemented by expanding digital commerce capabilities.
Bluegem III, which held its final close in February 2026, has deployed capital across five investments to date in resilient consumer subsectors. The Suavinex transaction represents the firm's continued focus on acquiring established European consumer brands with differentiated products, operational scale, and growth potential. The combination with Béaba positions the merged entity to pursue expansion across continental European markets and strengthen its global footprint in the specialized baby care category.
Suavinex brings substantial operational assets and intellectual property to the combined entity. The company, founded in 1980, operates a fully vertically integrated business model with in-house manufacturing facilities in Spain and Slovakia, proprietary engineering capabilities, and a portfolio of worldwide patented products. The company is recognized for innovation in baby care, having pioneered the three-position teat system in 1988—a foundational product that allows flow adaptation based on infant sucking patterns—and more recently launching the Zero-Zero product line featuring anti-colic technology underpinned by medical research.
The acquisition leverages existing market presence and distribution infrastructure. Suavinex generates the majority of revenues through direct sales in Spain via a dedicated sales agent network, while also maintaining dedicated sales teams in Italy, France, and China alongside broader global distribution through partner channels. The company has developed a loyal customer base with strong repeat purchase and recommendation patterns, complemented by expanding digital commerce capabilities.
Bluegem III, which held its final close in February 2026, has deployed capital across five investments to date in resilient consumer subsectors. The Suavinex transaction represents the firm's continued focus on acquiring established European consumer brands with differentiated products, operational scale, and growth potential. The combination with Béaba positions the merged entity to pursue expansion across continental European markets and strengthen its global footprint in the specialized baby care category.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.